🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
476.03
+15.70 (3.41%)
Nov 20, 2026, 3:16 PM EST - Market open

HCA Healthcare Stock Forecast

Stock Price Forecast

According to 26 analysts polled by S&P Global, HCA Healthcare stock has a consensus rating of "Buy" and an average price target of $485.68. The average 1-year stock price forecast is 2.03% higher than the current stock price, while the lowest is $380 (-20.17%) and the highest is $585 (+22.89%).

Price Target: $485.68 (+2.03%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$380$485.68$488$585
Change-20.17%+2.03%+2.51%+22.89%

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy131313141414
Buy211111
Hold910101099
Sell000011
Strong Sell111111
Total252525262626

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bernstein
Bernstein
Hold
Maintains
$471
HoldMaintains$471-1.06%Nov 19, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
$425 → $475
HoldMaintains$425 → $475-0.22%Nov 18, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$570
BuyMaintains$570+19.74%Nov 16, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
n/a
HoldMaintainsn/an/aNov 5, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$381 → $468
HoldMaintains$381 → $468-1.69%Nov 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
79.18B
from 75.60B
Increased by 4.74%
Revenue Next Year
81.66B
from 79.18B
Increased by 3.13%
EPS This Year
30.09
from 28.21
Increased by 6.65%
EPS Next Year
31.29
from 30.09
Increased by 4.00%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
58.75B60.23B64.97B70.60B75.60B79.18B
Revenue Growth
14.01%2.52%7.86%8.67%7.08%4.74%
Gross Profit
22.49B23.18B25.58B28.68B31.37B34.05B
Gross Margin
38.28%38.48%39.37%40.62%41.50%43.00%
Operating Income
9.68B9.05B9.63B10.55B11.97B12.12B
Net Income
6.96B5.64B5.24B5.76B6.78B6.64B
EPS
----28.2130.09
EPS Growth
----28.46%6.65%
Forward PE
14.1113.4514.2512.6015.9015.82
Dividend / Share
1.922.242.402.642.883.11
Dividend Growth
346.51%16.67%7.14%10.00%9.09%8.14%
Free Cash Flow
----7.69B6.94B
No. Analysts
-----22
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High79.5B
Avg79.2B
Low78.9B

Revenue Growth

Revenue Growth202620272028
High
5.1%
Avg
4.7%
Low
4.3%

EPS Forecast

EPS202620272028
High30.43
Avg30.09
Low29.15

EPS Growth

EPS Growth202620272028
High
7.9%
Avg
6.7%
Low
3.3%